Meth and cocaine addiction treatment in Vermont: contingency management and other options
In Vermont, the stimulant story is mostly a cocaine story. Vermont Department of Health data show cocaine was involved in 162 of the 225 overdose deaths among Vermont residents in 2024, close behind fentanyl. Ten years earlier, in 2015, the count was 14. Methamphetamine shows up far less often in Vermont deaths, but it has grown too.
This guide is for anyone in Vermont trying to figure out what help exists for cocaine, crack, meth or prescription stimulant misuse. It focuses on the treatment with the strongest research behind it, contingency management, and on how Vermont has started offering it through its Preferred Provider network.
Vermont Recovery Guide is operated by Treatment Outreach, an independent service. We are not a medical provider, and this page does not give medical or legal advice. If someone has chest pain, a seizure, extreme agitation or is not breathing normally, call 911. For a mental health or substance use crisis, call or text 988.
What the Vermont numbers show
The Health Department's July 2025 brief, Substances Involved in Overdose Deaths of Vermont Residents, tracks each drug listed on death certificates:
| Substance | 2015 deaths | 2024 deaths |
|---|---|---|
| Fentanyl | 28 | 170 |
| Cocaine | 14 | 162 |
| Methamphetamine | 0 | 26 |
The brief notes that since 2022, deaths involving opioids have fallen while the involvement of many non-opioid drugs has risen or held steady, and that deaths involving xylazine have kept increasing. A drug can be counted in more than one row, because most deaths involve more than one substance.
The practical takeaway: in Vermont, cocaine use is rarely "just" cocaine. Treatment and safety planning need to account for opioids and xylazine as well.
Is there a medication for cocaine or meth addiction?
No, not one approved for the purpose. The National Institute on Drug Abuse (NIDA) states that there are currently no FDA-approved medications to treat cocaine use disorder, and no FDA-approved medication for methamphetamine use disorder or any other stimulant use disorder. That is different from opioid use disorder, which Vermont treats with medications through its Hub and Spoke system (see our Suboxone and methadone guide).
What does work, according to NIDA and SAMHSA, are behavioral treatments. SAMHSA's Treatment of Stimulant Use Disorders resource guide highlights four: contingency management, cognitive behavioral therapy, the community reinforcement approach and motivational interviewing. NIDA notes that behavioral therapies have proven effective in both residential and outpatient settings.
Contingency management, explained
Contingency management (CM) sounds unusual the first time you hear it: people earn rewards for not using. The Vermont Department of Health describes it as the systematic delivery of positive reinforcement for goal behaviors, with tangible items such as gift cards or reloadable debit cards earned for a stimulant-negative urine drug test or for things like attending therapy.
A few points that help it make sense:
- It rewards progress you can verify. Tests and attendance are checked, so the reward is tied to something concrete.
- It is the best-studied option for meth. NIDA calls CM the behavioral treatment most associated with success for methamphetamine use disorder.
- It is not a stand-alone cure. CM usually sits inside an outpatient or intensive outpatient program alongside counseling.
Where Vermont offers contingency management
Vermont pays for CM differently from states that cover it through a Medicaid waiver. In a May 22, 2026 presentation to the state's Opioid Settlement Advisory Committee, the Health Department's Division of Substance Use Programs reported that:
- Vermont was the first state to fund CM with opioid settlement funds, with grant agreements beginning in fiscal year 2024.
- 15 providers were offering CM at 20 locations, with about 750 clients enrolled.
- CM was available in outpatient, intensive outpatient and Hub settings, using protocols based on negative drug tests, attendance, or a mix.
- The department brought in technical assistance from the University of Vermont to train and coach Preferred Provider staff.
The same presentation is candid about limits: some areas of Vermont still have no CM, transportation is a barrier, programs depend on having enough staff, and because the money is appropriated each year, providers worry about long-term funding. So CM may not be available everywhere or at every program.
How to find it: ask VT Helplink, or ask any Preferred Provider directly, "Do you offer contingency management for stimulant use?" If the answer is no, ask whether they offer cognitive behavioral therapy or another stimulant-focused approach, or can refer you to a program that does.
Getting connected: VT Helplink and Preferred Providers
Vermont's front door for substance use treatment is VT Helplink. The Health Department lists the numbers as 802-565-LINK (5465) and toll-free 833-565-LINK (5465). Our guide on how to get into rehab in Vermont walks through how Helplink assessments and intake work.
VT Helplink describes its Preferred Provider Network as treatment and recovery providers across Vermont that work together so people can get care regardless of income, and that meet standards set by the state's Division of Substance Use Programs. That network is also where the state's CM grants have gone.
Matching the level of care to the situation
Most stimulant treatment happens in outpatient programs, but not everyone should start there. A clinical assessment looks at how heavy the use is, other substances, mental health, housing and safety.
- Intensive outpatient and partial hospitalization offer structured treatment several days a week, which is where many CM and CBT programs run.
- Residential treatment can help when someone cannot stop while at home or keeps relapsing.
- Detox / withdrawal management may be needed when cocaine use is mixed with opioids, xylazine, alcohol or benzodiazepines.
Our levels of care page explains each option.
When it's more than a treatment question
Stimulants can cause medical and psychiatric emergencies. NIDA describes cocaine binges leading to irritability, panic attacks, paranoia and even psychosis, including hearing or seeing things that are not there; methamphetamine can cause a racing heart, stroke and "overamping." After heavy use stops, a crash with depression, anxiety, poor sleep and intense cravings is common, and NIDA says low mood and cravings can last for months.
Call 911 for physical danger or violent agitation, and 988 for suicidal thoughts or a mental health crisis. Ask any program you consider whether it treats co-occurring depression, anxiety or trauma, because those often travel with stimulant use.
Fentanyl and xylazine in the supply
Because fentanyl and xylazine appear alongside cocaine in so many Vermont deaths, anyone using stimulants, and the people around them, should carry naloxone. Our Vermont naloxone guide explains how to get free kits by mail and Overdose Prevention Packs with fentanyl and xylazine test strips. Families can also find support in helping a loved one with addiction.
Paying for stimulant treatment
Vermont expanded Medicaid, administered by the Department of Vermont Health Access; see our Vermont Medicaid page for eligibility. Without insurance, Helplink can point you to Preferred Providers. Private plans are covered in our insurance guide.
Frequently asked questions
Does Vermont offer contingency management for cocaine or meth?
Yes, at some programs. The Vermont Department of Health reported in May 2026 that 15 providers offered contingency management at 20 locations, funded with opioid settlement money, with about 750 clients enrolled. It is not available everywhere, so ask VT Helplink or the program.
How many Vermont overdose deaths involve cocaine?
The Vermont Department of Health reports that cocaine was involved in 162 of the 225 overdose deaths among Vermont residents in 2024, up from 14 in 2015. Methamphetamine was involved in 26.
Is there a pill that treats cocaine addiction?
No. NIDA says there are no FDA-approved medications for cocaine use disorder or any other stimulant use disorder. Behavioral treatments such as contingency management and cognitive behavioral therapy are the core of care.
What number do I call in Vermont to find treatment?
VT Helplink: 802-565-LINK (5465) or toll-free 833-565-LINK (5465), according to the Vermont Department of Health. In a crisis, call or text 988; in an emergency, call 911.
Can I get stimulant treatment in Vermont without insurance?
Possibly. VT Helplink says its Preferred Provider Network works to make care available regardless of income. Ask Helplink to connect you with a Preferred Provider.
Sources
- Vermont Department of Health, Substances Involved in Overdose Deaths of Vermont Residents (July 2025): https://www.healthvermont.gov/sites/default/files/document/dsu-substances-involved-overdose-deaths.pdf
- Vermont Department of Health, OSAC Program Outcome Presentation (May 22, 2026): https://www.healthvermont.gov/sites/default/files/document/dsu-osac-program-outcome-presentation.pdf
- Vermont Department of Health, How to Get Help: https://www.healthvermont.gov/alcohol-drugs/how-get-help
- VT Helplink, Treatment: https://vthelplink.org/treatment/
- NIDA, Cocaine: https://nida.nih.gov/research-topics/cocaine
- NIDA, Methamphetamine: https://nida.nih.gov/research-topics/methamphetamine
- SAMHSA, Treatment of Stimulant Use Disorders (PEP20-06-01-001, 2020): https://library.samhsa.gov/product/treatment-stimulant-use-disorders/pep20-06-01-001
- 988 Suicide & Crisis Lifeline: https://988lifeline.org